Genomic landscape of adult mixed phenotype acute leukemia (MPAL).

Authors

null

Kiyomi Morita

The University of Texas MD Anderson Cancer Center, Houston, TX

Kiyomi Morita , Feng Wang , Keyur Patel , Carlos E. Bueso-Ramos , Abdallah Abou Zahr , Curtis Gumbs , Jianhua Zhang , Xingzhi Song , Marisela Mendoza , Chang-jiun Wu , Steven Kornblau , Courtney Denton Dinardo , Farhad Ravandi , Guillermo Garcia-Manero , Elias Jabbour , Michael Andreeff , Hagop M. Kantarjian , Marina Konopleva , Andrew Futreal , Koichi Takahashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Acute Leukemia

Citation

J Clin Oncol 35, 2017 (suppl; abstr 7023)

DOI

10.1200/JCO.2017.35.15_suppl.7023

Abstract #

7023

Poster Bd #

223

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

Phase I study of BP1001 (Liposomal Grb2 Antisense) in patients with hematologic malignancies.

Phase I study of BP1001 (Liposomal Grb2 Antisense) in patients with hematologic malignancies.

First Author: Maro Ohanian

Poster

2022 ASCO Quality Care Symposium

Family history screening following new diagnoses of leukemia versus solid malignancies.

Family history screening following new diagnoses of leukemia versus solid malignancies.

First Author: Benjamin Aaron Bleiberg

First Author: Taylor J. Jensen

Poster

2020 ASCO Virtual Scientific Program

Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.

Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.

First Author: Michael Ozga